PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Hansoh Pharmaceutical Group Co Ltd (3692.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG549581067
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapHK$86.90B
PE Ratio30.54
Revenue (TTM)HK$9.46B
Gross Profit (TTM)HK$8.51B
EBITDA (TTM)HK$2.77B
Year RangeHK$9.28 - HK$17.24
Target PriceHK$16.92

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 3692.HK

Hansoh Pharmaceutical Group Co Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Hansoh Pharmaceutical Group Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%80.00%OctoberNovemberDecember2024FebruaryMarch
-18.14%
81.97%
3692.HK (Hansoh Pharmaceutical Group Co Ltd)
Benchmark (^GSPC)

S&P 500

Returns By Period

Hansoh Pharmaceutical Group Co Ltd had a return of -1.78% year-to-date (YTD) and 16.22% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-1.78%10.16%
1 month16.22%3.47%
6 months47.43%22.20%
1 year16.22%30.45%
5 years (annualized)N/A13.16%
10 years (annualized)N/A10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-25.63%17.75%
2023-19.05%6.00%38.27%7.33%-0.38%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Hansoh Pharmaceutical Group Co Ltd (3692.HK) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
3692.HK
Hansoh Pharmaceutical Group Co Ltd
0.32
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Hansoh Pharmaceutical Group Co Ltd Sharpe ratio is 0.32. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
0.32
2.77
3692.HK (Hansoh Pharmaceutical Group Co Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

Hansoh Pharmaceutical Group Co Ltd granted a 1.24% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.19 per share.


PeriodTTM202320222021
DividendHK$0.19HK$0.19HK$0.14HK$0.08

Dividend yield

1.24%1.21%0.94%0.41%

Monthly Dividends

The table displays the monthly dividend distributions for Hansoh Pharmaceutical Group Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.05HK$0.00HK$0.00HK$0.14HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.09HK$0.00HK$0.00HK$0.05HK$0.00HK$0.00HK$0.00
2021HK$0.08HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%1.2%
Hansoh Pharmaceutical Group Co Ltd has a dividend yield of 1.24%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%20.6%
Hansoh Pharmaceutical Group Co Ltd has a payout ratio of 20.59%, which is quite average when compared to the overall market. This suggests that Hansoh Pharmaceutical Group Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-64.88%
0
3692.HK (Hansoh Pharmaceutical Group Co Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Hansoh Pharmaceutical Group Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hansoh Pharmaceutical Group Co Ltd was 78.64%, occurring on Aug 21, 2023. The portfolio has not yet recovered.

The current Hansoh Pharmaceutical Group Co Ltd drawdown is 64.88%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.64%Jan 25, 2021633Aug 21, 2023
-21.59%Sep 4, 201967Dec 9, 201935Feb 3, 2020102
-20%Jul 24, 202011Aug 7, 2020101Jan 5, 2021112
-18.75%Mar 9, 202011Mar 23, 202034May 14, 202045
-15.81%Jul 8, 201921Aug 5, 201914Aug 23, 201935

Volatility

Volatility Chart

The current Hansoh Pharmaceutical Group Co Ltd volatility is 13.85%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%OctoberNovemberDecember2024FebruaryMarch
13.85%
2.80%
3692.HK (Hansoh Pharmaceutical Group Co Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hansoh Pharmaceutical Group Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items